German version of the Unité Rhumatologique des Affections de la Main (URAM) scale in Dupuytren's disease: the need for a uniform definition of recurrence. Comment on the article by Beaudreuil et al.
Relationship Among Treatment, Pruritus, Investigator's Static Global Assessment, and Quality of Life in Patients with Atopic Dermatitis.
Autorzy:
Simpson EL; Oregon Health and Science University, Portland, OR, USA. . Tom WL; UC San Diego and Rady Children's Hospital-San Diego, San Diego, CA, USA. Bushmakin AG; Pfizer Inc., Groton, CT, USA. Cappelleri JC; Pfizer Inc., Groton, CT, USA. Yosipovitch G; Department of Dermatology, Miami Itch Center, Miller School of Medicine, University of Miami, Miami, FL, USA. Ständer S; Center for Chronic Pruritus, University Hospital Münster, Münster, Germany. Luger T; Department of Dermatology, University Hospital Münster, Münster, Germany. Sanders P; Pfizer Ltd., Surrey, UK. GerberRA; Pfizer Inc., Groton, CT, USA. Myers DE; Pfizer Inc., Collegeville, PA, USA.
Pokaż więcej
Źródło:
Dermatology and therapy [Dermatol Ther (Heidelb)] 2021 Apr; Vol. 11 (2), pp. 587-598. Date of Electronic Publication: 2021 Mar 09.
Real-World Comparative Effectiveness of Tofacitinib and Tumor Necrosis Factor Inhibitors as Monotherapy and Combination Therapy for Treatment of Rheumatoid Arthritis.
Autorzy:
Reed GW; Corrona Research Foundation, Albany, NY, USA. .; University of Massachusetts Medical School, Worcester, MA, USA. . GerberRA; Pfizer Inc, Groton, CT, USA. Shan Y; Corrona, LLC, Waltham, MA, USA. Takiya L; Pfizer Inc, Collegeville, PA, USA. Dandreo KJ; Corrona, LLC, Waltham, MA, USA. Gruben D; Pfizer Inc, Groton, CT, USA. Kremer J; Albany Medical College, Albany, NY, USA. Wallenstein G; Pfizer Inc, Groton, CT, USA.
Pokaż więcej
Źródło:
Rheumatology and therapy [Rheumatol Ther] 2019 Nov 09. Date of Electronic Publication: 2019 Nov 09.
Tofacitinib versus Biologic Treatments in Moderate-to-Severe Rheumatoid Arthritis Patients Who Have Had an Inadequate Response to Nonbiologic DMARDs: Systematic Literature Review and Network Meta-Analysis.
Autorzy:
Bergrath E; Mapi, Boston, MA, USA. GerberRA; Pfizer Inc., Groton, CT, USA. Gruben D; Pfizer Inc., Groton, CT, USA. Lukic T; Pfizer Inc., New York City, NY, USA. Makin C; Mapi, Boston, MA, USA. Wallenstein G; Pfizer Inc., Groton, CT, USA.
Isolated and spontaneous correction of proximal interphalangeal joint contractures in Dupuytren's disease: an exploratory analysis of the efficacy and safety of collagenase Clostridium histolyticum.
Determining clinically important changes in range of motion in patients with Dupuytren's Contracture: secondary analysis of the randomized, double-blind, placebo-controlled CORD I study.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies